Scrapie prion protein accumulation by scrapie-infected neuroblastoma cells abrogated by exposure to a prion protein antibody
AUTOR(ES)
Enari, Masato
FONTE
The National Academy of Sciences
RESUMO
Exposure of susceptible neuroblastoma N2a cells to mouse scrapie prions leads to infection, as evidenced by the continued presence of the scrapie form of the prion protein (PrPSc) and infectivity after 300 or more cell doublings. We find that exposure to phosphatidylinositol-specific phospholipase C (PIPLC) or to the monoclonal anti-prion protein (PrP) antibody 6H4 not only prevents infection of susceptible N2a cells but also cures chronically scrapie-infected cultures, as judged by the long-term abrogation of PrPSc accumulation after cessation of treatment. A nonpassaged, stationary infected culture rapidly loses PrPSc when exposed to the antibody or PIPLC, indicating that the PrPSc level is determined by steady state equilibrium between formation and degradation, and that depletion of the cellular form of PrP can interrupt the propagation of PrPSc. These findings encourage the belief that passive immunization may provide a therapeutic approach to prion disease.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=55414Documentos Relacionados
- Prion protein biosynthesis in scrapie-infected and uninfected neuroblastoma cells.
- Scrapie-infected murine neuroblastoma cells produce protease-resistant prion proteins.
- Analyses of frequency of infection, specific infectivity, and prion protein biosynthesis in scrapie-infected neuroblastoma cell clones.
- Heterologous PrP molecules interfere with accumulation of protease-resistant PrP in scrapie-infected murine neuroblastoma cells.
- In vitro expression in eukaryotic cells of a prion protein gene cloned from scrapie-infected mouse brain.